Vitamin D and bone health; Potential mechanisms

Nutrients

Volumn 2, Issue 7, 2010, Pages 693-724

  Laird, Eamon ^a   Ward, Mary ^a   McSorley, Emeir ^a   Strain, J J ^a   Wallace, Julie ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Bone; Cytokines; Fracture bone mineral density; Muscle strength; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; VITAMIN D;

BONE DENSITY; BONE METABOLISM; CONSTIPATION; CYTOKINE RELEASE; FALLING; FRACTURE; HIP FRACTURE; HUMAN; HYPERCALCEMIA; IMMUNOREGULATION; INCIDENCE; INFLAMMATION; MUSCLE FUNCTION; MUSCLE STRENGTH; NAUSEA; NEPHROLITHIASIS; OSTEOMALACIA; POPULATION RESEARCH; REVIEW; RICKETS; RISK ASSESSMENT; SIDE EFFECT; SOFT TISSUE CALCIFICATION; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; VOMITING; WEAKNESS; WEIGHT REDUCTION;

EID: 79952080236     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu2070693     Document Type: Review

References (188)

1. Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases cancers, and cardiovascular disease. Am. J. Clin. Nut. 2004, 80, 1678S-1688S.
2. Diamond, T.H.; Eisman, J.A.; Mason, R.S.; Nowson, C.A.; Pasco, J.A.; Sambrook, P.N; Wark, J.D. Working Group of the Australian and New Zealand Bone and Mineral Society; Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: A position statement. MJA 2005, 182, 281-285.
3. Holick, M.F. McCollum Award Lecture, Vitamin D: New Horizons for the 21st Century. Am. J. Clin. Nut. 1994, 60, 619-630.
4. Holick, M.F. Vitamin D: a millennium perspective. J. Cell. Biochem. 2003, 88, 296-307.
5. Chen, T. Factors that affect the cutaneous synthesis and dietary sources of vitamin D. Arch. Biochem. Biophysics 2007, 460, 213-217.
6. Matsuoka, L.Y.; Ide, L.; Wortsman, J.; MacLaughlin, J.A.; Holick, M.F. Sunscreens suppress vitamin D3 synthesis. J. Clin. Endocrinol. Metab. 1987, 64, 1165-1168.
7. Holick, M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 1995, 61, 638S-645S.
8. Josefsson, W.; Landelius, T. Effects of clouds on UV irradiance as estimated from cloud amount, cloud type, precipitation, global radiation and sunshine duration. J. Geo. Research. 2000, 105, 4927-4935.
9. Agarwal, K.S.; Mughal, M.Z.; Upadhyay, P.; Berry, J.L.; Mawer, E.B.; Puliyel, J.M. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch. Dis. Child. 2002, 87, 111-113.
10. Matsuoka, L.Y.; Wortsman, J.; Haddad, J.G.; Kolm, P.; Hollis, B.W. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch. Dermatol. 1991, 127, 536-538.
11. MacLaughlin, J.; Holick, M.F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest. 1985, 76, 1536-1538.
12. Holick M.F.; Biancuzzo, R.M.; Chen, T.C.; Klein, E.K.; Young, A.; Douglass, B.; Reitz, R.; Salameh, W.; Ameri, A.; Tannenbaum, A.D. Vitamin D2 is as effective as Vitamin D3 in maintaining circulating concentrations of 25-Hydroxyvitamin D status. J. Clin. Endocrinol. Metab. 2008, 93, 677-681.
13. Trang, H.M.; Cole, D.E.; Rubin, L.A.; Pierratos, A.; Siu, S.; Vieth, R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nut. 1998, 68, 854-858.
14. Armas, L.A.; Hollis, B.W.; Heaney, R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab. 2004, 89, 5387-5391.
15. Hill, T.R.; O'Brien, M.M.; Cashman K.D.; Flynn, A.; Kiely, M. Vitamin D intakes in 18-64 year old Irish adults Eur. J. Clin. Nut. 2004, 58, 1509-1517.
16. British Paediatric Association. Hypercalcaemia in infants and vitamin D. BMJ 1956, 2, 149.
17. Chen, T.C.; Heath, H.; Holick, M.F. An update on the vitamin D content of fortified milk from the United States and Canada. N. Engl. J. Med. 1993, 329, 1507.
18. Calvo, M.S.; Whiting, S.J.; Barton, C.N. Vitamin D fortification in the United States and Canada: current status and data needs. Am. J. Clin. Nutr. 2004, 80, 1710S-1716S.
19. Bikle, D. Vitamin D Insufficiency/Deficiency in Gastrointestinal Disorders. J. Bone. Min. Res. 2007, 22, 2.
20. Avioii, L.V. Absorption and metabolism of vitamin D3 in man. Am. J. Clin. Nutr. 1969, 22, 437-446.
21. Driscoll, R.H.; Meredith, S.C.; Sitrin, M.; Rosenberg, I.H. Vitamin D deficiency and bone disease in patients with Crohns disease. Gastroenterology 1982, 83, 1252-1258.
22. Sitrin, M.D.; Pollack, K.L.; Bolt, M.G.; Rosenberg, I.H. Comparison of vitamin D and 25-hydroxyvitamin D absorption in the rat. Am. J. Physiol. 1982, 242, G326.
23. Bouillon, R. Vitamin D: from photosynthesis, metabolism, and action to clinical applications. In Endocrinology, 3rd ed.; De Groot, L., Jameson, J.L., Burger, H.G., Eds.; Saunders: Philadelphia, USA, 2001; pp. 1009-1028.
24. Holick, M.F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 2006, 116, 2062-2072.
25. Khosla, S. The OPG/RANKL/RANK system. Endocrinology 2001, 142, 5050-5055.
26. Zittermann, A.; Schleithoff, S.S.; Tenderich, G.; Berthold, H.K.; Korfre, R.; Stehle, P. Low vitamin D status: a contributing factorin the pathogenesis of congestive heart failure? J. Am. Coll. Cardiol. 2003, 41, 105-112.
27. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
28. Food Safety Authority of Ireland [FSAI] [1999]: Recommended Dietary Allowances for Ireland; Government Publications Sales Office: Dublin, Ireland, 1999.
29. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report 41. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy; HMSO: London, UK, 1997.
30. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for Calcium, Magnesium, Phosphorus, Vitamin D and Fluoride; National Academy Press: Washington, DC, USA, 1997.
31. FAO/World Health Organization. Human vitamin and mineral requirements: a report of the joint FAO/WHO expert consultation, Bangkok, Thailand; Food and Nutrition Division: Rome, Italy, 1996.
32. UK Department of Health. Nutrition and bone health: with particular reference to calcium and vitamin D. Report on Health and Social subjects; The Stationary Office: London, United Kingdom 1998.
33. McKenna, M.; Freaney, R.; Meade, A.; Muldowney, F. Hypovitaminosis D and elevated serum alkaline phosphatase in elderly Irish people. Am. J. Clin. Nutr. 1985, 41, 101-109.
34. McKenna, M.; Freaney, R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos. Int. 1998, 8, S3-S6.
35. Zittermann, A.; Scheld, K.; Stehle, P. Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur. J. Clin. Nutr. 1998, 52, 501-506.
36. Van der Wielen, R.P.; Lowik, M.R.; Van den Berg, H.; De Groot, LC.; Haller, J.; Moreiras, O.; van Staveren, W.A. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346, 207-210.
37. McKenna, M. Differences in vitamin D status between countries in young adults and elderly. Am. J. Med. 1992, 93, 69-77.
38. Cashman, K.D.; Hill, T.R.; Lucey, A.J.; Taylor, N.; Seamans, K.M.; Muldowney, S.; Fitzgerald, A.P.; Flynn, A.; Barnes, M.S.; Horigan, G. Estimation of the dietary requirement for vitamin D in healthy adults. Am. J. Clinl. Nut. 2008, 88, 1535-1542.
39. Hill, T.R.; O'Brien, M.M.; Cashman, K.D.; Flynn, A.; Kiely, M. Vitamin D intakes in 18-64 year old Irish adults Eur. J. Clin. Nut. 2004, 58, 1509-1517.
40. Henderson, L.; Irving, K.; Gregory, J.; Bates, C.J.; Prentice, A.; Perks, J.; Swan, G.; Farron, M. The National Diet and Nutrition Survey: adults aged 19 to 64 years-vitamin and mineral intake and urinary analysis. Volume 3; HMSO: London, UK, 2003.
41. Park, Y.K.; Barton, C.N.; Calvo, M.S. Dietary contributions to serum 25 [OH] vitamin D levels [25[OH] D] differ in black and white adults in the United States: Results from NHANES III. J. Bone Miner. Res. 2001, 16, F281.
42. Rasmussen, L.B.; Hansen, G.L.; Hansen, E.; Koch, B.; Mosekilde, L.; Mølgaard, C.; Sørensen, O.H.; Ovesen, L. Vitamin D: should the supply in the Danish population be increased? Int. J. Food Sci. Nutr. 2001, 51, 209-215.
43. Ovesen, L.; Andersen, R.; Jakobsen, J. Geographical differences in vitamin D status, with particular reference to European countries. Proc. Nutr. Soc. 2003, 62, 813-821.
44. Van Der Wielen, R.P.J.; Lowik, M.R.H.; Van Den Berg, H.; De Groot, L.; Haller, J.; Moreiras, O.; Van Staveren, W.A. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995, 346, 207-210.
45. Barnes, M.S.; Robson, J.P.; Bonham, M.P.; Strain, J.; Wallace, J. Vitamin D: Status, Supplementation and Immunodulation. Cur. Nut. Food. Sci. 2006, 2, 315-336.
46. Vieth, R.; Chan, P.; MacFarlane, G. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level [LOAEL. Am. J. Clin. Nutr. 2001, 73, 288-294.
47. Todd, M.A.; Bailey, R.R.; Espiner, E.A.; Lynn, K.L. Vitamin D2 for the treatment of chilblains-a cautionary tale. N Z. Med. J. 1987, 100, 465.
48. Barrueto F., Jr.; Wang-Flores, H.H.; Howland, M.A.; Hoffman, R.S.; Nelson, L.S. Acute vitamin D intoxication in a child. Pediatrics 2005, 116, E453-456.
49. Vieth, R.; Pinto, T.R.; Reen, B.S.; Wong, M.M. Vitamin D poisoning by table sugar. Lancet 2002, 359-672.
50. Matkovic, V.; Jelic, T.; Wardlaw, G.M.; Ilich, J.Z.; Goel, P.K.; Wright, J.K.; Andon, M.B.; Smith, K.T.; Heaney, R.P. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. J. Clin. Invest. 1994, 93, 799-808.
51. Heaney, R.P.; Abrams, S.; Dawson-Hughes, B.; Looker, A.; Marcus, R.; Matkovic, V.; Weaver, C. Peak bone mass Osteoporos. Int. 2000, 11, 985-1009.
52. Seeman, E. The effects of tobacco and alcohol use on bone. In Osteoporosis, 1st ed.; Marcus, R., Feldman, D., Kelsey, J., Eds.; Calif Academic Press Inc: San Diego, USA, 1996; pp. 577-598.
53. Emaus, N.; Berntsen, G.K.; Joakimsen, R.M.; V Fønnebø. Longitudinal changes in forearm bone mineral density in women and men aged 25-44 years: the Tromsø Study: a population-based study. Am. J. Epidemiol. 2005, 162, 633-643.
54. Weitzmann, N.M.; Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale J. Clin. Invest. 2006, 116, 1186-1194.
55. Slemenda, C.W.; Hui, S.L.; Longcope, C.; Wellman, H.; Johnston, C.C., Jr. Predictors of bone mass in perimenopausal women. Ann. Intern. Med. 1990, 112, 96-101.
56. Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrinology. Rev. 2001, 22, 477-501.
57. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. World Health Organisation, Geneva, Switzerland, 1994.
58. Binkley, N.C.; Schmeer, P.; Wasnich, R.D.; Lenchik, L. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J. Clin. Densitom. 2002, 5, 219-227.
59. Cummings, S.R.; Black, D.M.; Nevitt, M.C.; Browner, W.; Cauley, J.; Ensrud, K.; Genant, H.K.; Palermo, L.; Scott, J.; Vogt, T.M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993, 341, 72-75.
60. Marshall, D.; Johnell, O.; Wedel, H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312, 1254-1259.
61. Delmas, P.D.; Marin, F.; Marcus, R.; Misurski, D.A.; Mitlak, B.H. Beyond Hip: Importance of Other Nonspinal Fractures. Am. J. Med. 2007, 120, 381-387.
62. Haentjens, P.; Autier, P.; Barette, M.; Boonen, S. The economic cost of hip fractures among elderly women. A one year prospective, observational cohort study with matched pair analysis. Belgian Hip Fracture Study Group. J. Bone. Joint. Surg. Am. Ed. 2001, 83, 493-500.
63. Cooper, C. The crippling consequences of fractures and their impact on quality of life. Am. J. Med. 1997, 103, 12S-17S.
64. Cauley, J.A.; Thompson, D.E.; Ensrud, K.C.; Scott, J.C.; Black, D. Risk of mortality following clinical fractures. Osteo. Intern. 2000, 11, 556-561.
65. Melton, L.J. Hip fractures: a worldwide problem today and tomorrow. Bone 1993, 14, S1-8.
66. Heikinheimo, R.J.; Inkovaara, J.A.; Harju, E.J.; Haavisto, M.V.; Kaarela, R.H.; Kataja, J.M.; Kokko A.L.; Kolho, L.A.; Rajala, S.A. Annual injection of vitamin D and fractures of aged bones. Calcified. Tissue. Int. 1992, 51, 105-110.
67. Hayashi, Y.; Fujita, T.; Inoue, T. Decrease of vertebral fracture in osteoporosis by administration of 1a-hydroxyvitamin D3. J. Bone. Min. Res. 1992, 10, 184-188.
68. Tilyard, M.W.; Spears, G.F.S.; Thomson, J.; Dovey, S. Treatment of postmenopausal osteoporosis with calcitriol and calcium. N. Engl. J. Med. 1992, 326, 357-362.
69. Lips, P.; Graafmans, W.C.; Ooms, M.E.; Bezemer, P.D.; Bouter, L.M. Vitamin D supplementation and fracture incidence in elderly persons. Ann. Intern. Med. 1996, 124, 400-406.
70. Sato, Y.; Manabe, S.; Kuno, H.; Oizumi, K. Amelioration of osteopenia and hypovitaminosis D by 1a-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J. Neurosurg. Psychiatry 1999, 66, 64-68.
71. Peacock, M.; Liu, G.; Carey, M.; McClintock, R.; Ambrosius, W.; Hui, S.; Johnston, C.C. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J. Clin. Endocrinol. Metab. 2000, 85, 3011-3019.
72. Ebeling, P.R.; Wark, J.D.; Yeung, S.; Poon, C.; Salehi, N.; Nicholson, G.C.; Kotowicz, M. A Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-years randomized, double blind, double placebo study. J. Clin. Endocr. Metab. 2001, 86, 4096-4103.
73. Gallagher, J.C.; Fowler, S.E.; Detter, J.R.; Sherman, S.S. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J. Clin. Endocrinol. Metab. 2001, 86, 3618-3628.
74. Meyer, H.E.; Smedshaug, G.B.; Kvaavik, E.; Falch, J.A.; Tverdal, A.; Pedersen, J.I. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J. Bone. Miner. Res. 2002, 17, 709-715.
75. Trivedi, D.P.; Doll, R.; Khaw, K.T. Effect of four monthly oral vitamin D3 [cholecalciferol] supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326, 469.
76. Grant, A.M.; Avenell, A.; Campbell, M.K.; Cooper, C.; Donaldson, C.; Francis, R.M.; Gillespie, W.J.; Robinson, C.M.; Torgerson, D.J. Oral vitamin D3 and calcium for secondary prevention of low trauma fractures in elderly people (Randomised Evaluation of Calcium Or Vitamin D, RECORD): a randomized placebo-controlled trial. Lancet 2005, 365, 1621-1628.
77. Sato, Y.; Iwamoto, J.; Kanoko, T.; Satoh, K. Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial. Cerebrovasc. Dis. 2005, 20, 187-192.
78. Law, M.; Withers, H.; Morris, J.; Anderson, F. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 2006, 35, 482-486.
79. Lyons, R.A.; Johansen, A.; Brophy, S.; Newcombe, R.; Phillips, C.; Lervy, B.; Evans, R.; Wareham, K.; Stone, M. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos. Int. 2007, 18, 811-818.
80. Smith, H.; Anderson, F.; Raphael, H.; Maslin, P.; Crozier, S.; Cooper, C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 2007, 46, 1852-1857.
81. Chapuy, M.C.; Arlot, M.E.; Duboeuf, F.; Brun, J.; Crouzet, B.; Arnaud, S.; Delmas, P.D.; Meunier, P.J. Vitamin D3 and calcium to prevent hip fractures in elderly women. N. Engl. J. Med. 1992, 327, 1637-1642.
82. Orimo, H.; Shiraki, M.; Hayashi, Y.; Hoshino, T.; Onaya, T. Effects of 1a-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif. Tissue. Int. 1994, 54, 370-376.
83. Shiraki M.; Kushida K.; Yamazaki K.; Nagai T.; Inoue T.; Orimo H. Effects of 2 year's treatment of osteoporosis with 1a-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double blind prospective study. Endocr. J. 1996, 43, 211-220.
84. Dawson-Hughes, B.; Harris, S.S.; Krall, E.A.; Dallal, G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 1997, 337, 670-676.
85. Komulainen, M.; Kroger, H.; Tuppurainen, M.T.; Heikkinen, A.M.; Alhava, E.; Honkanen, R.; Saarikoski, S. HRT and vitamin D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas 1998, 31, 45-54.
86. Stempfle, H.U.; Werner, C.; Echtler, S.; Wehr, U.; Rambeck, W.A.; Siebert, U; Üderfuhr, P; Angermann, C.E.; Theisen, K; Gärtner, R. Prevention of osteoporosis after cardiac transplantation. Transplantation. 1999, 68, 523-530.
87. Chapuy, M.C.; Pamphile, R.; Paris, E.; Kempf, C.; Schlichting, M.; Arnaud, S.; Garnero, P.; Meunier, P.J. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II Study. Osteoporos. Int. 2002, 13, 257-264.
88. Harwood, R.H.; Sahota, O.; Gaynor, K.; Masud, T.; Hosking, D.J. Nottingham Neck of Femur [NONOF] Study. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur [NONOF] Study. Age. Ageing. 2004, 33, 45-51.
89. Larsen, E.R.; Mosekilde, L.; Foldspang, A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J. Bone. Miner. Res. 2004, 19, 370-378.
90. Flicker, L.; MacInnis, R.J.; Stein, M.S.; Scherer, S.C.; Mead, K.E.; Nowson, C.A.; Thomas, J.; Lowndes, C.; Hopper, J.L.; Wark, J.D. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J. Am. Geriatr. Soc. 2005, 53, 1881-1888.
91. Porthouse, J.; Cockayne, S.; King, C.; Saxon, L.; Steele, E.; Aspray, T.; Baverstock, M.; Birks, Y.; Dumville, J.; Francis, R.; Iglesias, C; Puffer, S; Sutcliffe, A; Watt, I; Torgerson, D.J. Randomised controlled trial of calcium and supplementation with cholecalciferol [vitamin D3] for prevention of fractures in primary care. BMJ 2005, 330, 1003-1008.
92. Jackson, R.D.; LaCroix, A.Z.; Gass, M.; Wallace, R.B.; Robbins, J.; Bassford, T.; Berresford, S.; Black, H.; Blanchette, P.; Bonds, D. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354, 669-683.
93. Pfeifer, M.; Begerow, B.; Minne, H.W.; Suppan, K.; Fahrleitner-Pammer, A.; Dobnig, H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos. Int. 2009, 20, 315-322.
94. Chapuy, M.C.; Arlot, M.E.; Delmas, P.D.; Meunier, P.J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994, 308, 1081-1082.
95. Avenell, A.; Gillespie, W.J.; Gillespie, L.D.; O'Connell, D. Vitamin D and vitamin D analoques for preventing fractures associated with involutional and postmenopausalosteoporosis. Cochrane Database Syst. Rev. 2009, 2, Art. No.: CD000227. DOI: 10.1002/14651858.CD000227.pub3.
96. Tang, B.M.P.; Eslick, G.D.; Nowson, C.; Smith, C.; Bensoussan, A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007, 370, 657-666.
97. Bischoff-Ferrari, H.A.; Willett, W.C.; Wong, J.B.; Giovannucci, E.; Dietrich, T.; Dawson-Hughes, B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293, 2257-2264.
98. Boonen, S.; Lips, P.; Bouillon, R.; Bischoff-Ferrari, H.A; Vanderschueren, D.; Haentjens, P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a comparative meta-analysis of randomized controlled trials. J. Clin. Endocrinol. Metabol. 2007, 92, 1415-1423.
99. Bischoff-Ferrari, H.A.; Willett, W.C.; Wong, J.B.; Stuck, A.E.; Staehelin, H.B.; Orav, E.J.; Thoma, A.; Kiel, D.P.; Henschkowski, J. Prevention of non-vertebral fractures with oral vitamin D and dose dependency. A meta-analysis of randomized controlled trials. Arch. Intern. Med. 2009, 169, 551-561.
100. Avernell A.; Gillespie W.J.; Gillespie L.D.; O'Connell, D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst. Rev. 2005, 3, CD000227.
101. The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. B.M.J. 2010, 340, b5463.
102. Richy, F.; Schacht, E.; Bruyere, O.; Ethgen, O.; Gourlay, M.; Reginster, J.Y. Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis. Calcif. Tissue. Int. 2005, 76, 176-186.
103. Khaw, K.T.; Sneyd, M.J.; Compston, J. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle-aged women. Br. Med. J. 1992, 305, 273-277.
104. Bischoff-Ferrari, H.A; Dietrich, T.; Orav, E.J.; Dawson-Hughes, B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am. J. Med. 2004, 116, 634-639.
105. Nordin, B.E.C.; Baker, M.R.; Horsman, A.; Peacock, M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am. J. Clin. Nutr. 1985, 42, 470-474.
106. Ooms, M.E.; Roos, J.C.; Bezemer, P.D.; Van Der Vijgh, J.F.; Bouter, L.M.; Lips, P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J. Clin. Endocrinol. Metab. 1995, 80, 1052-1058.
107. Adams, J.S.; Kantorovich, V.; Wu, C.; Javanbakht, M.; Hollis, B.W. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J. Clin. Endocrinol. Metab. 1999, 84, 2729-2730.
108. Hunter D.; Major, P.; Arden, N.; Swaminathan, R.; Andrew, T.; MacGregor, A.J.; Keen, R.; Snieder, H.; Spector, T.D. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J. Bone. Miner. Res. 2000, 15, 2276-2283.
109. Patel R.; Collins D.; Bullock S.; Swaminathan R.; Blake G.M.; Fogelman I. The effect of season and vitamin D supplementation on bone mineral density in healthy women: A double-masked crossover study. Osteoporos. Int. 2001, 12, 319-325.
110. Dawson-Hughes B.; Dallal G.E.; Krall E.A.; Harris S.; Sokoll L.J.; Falconer G. Effect of vitamin D supplementationon wintertime and overall bone loss in healthy postmenopausal women. Ann. Intern. Med. 1991, 115, 505-512.
111. Sambrook P.; Birmingham J.; Kelly P.; Kempler S.; Nguyen T.; Pocock, N.; Eisman, J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N. Engl. J. Med. 1993, 328, 1747-1752.
112. Dawson Hughes, B.; Harris, S.S.; Krall, E.L.; Dallal, G.E.; Falconer, G.; Green, C.L. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am. J. Clin. Nutr. 1995, 61, 1140-1145.
113. Adachi J.D.; Bensen W.G.; Bianchi F.; Cividino A.; Pillersdorf S.; Sebaldt, R.J.; Tugwell, P.; Gordon, M.; Steele, M.; Webber, C.; Goldsmith, C.H. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J. Rheum. 1996, 23, 995-1000.
114. Bernstein C.N.; Seeger L.L.; Anton P.A.; Artinian L.; Geffrey, S.; Goodman, W.; Belin, T.R.; Shanahan, F. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment. Pharmacol. Ther. 1996, 10, 777-786.
115. Buckley, L.M.; Leib, E.S.; Cartularo, K.S.; Vacek, P.M.; Cooper, S.M. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann. Intern. Med. 1996, 125, 961-968.
116. Sato, Y.; Maruoka, H.; Oizumi, K. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1a-hydroxyvitamin D3 and calcium supplementation. Stroke 1997, 28, 736-739.
117. Baeksgaard, L.; Andersen, K.P.; Hyldstrup, L. Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporos. Int. 1998, 8, 255-260.
118. Lambrinoudaki, I.; Chan, D.T.; Lau, C.S.; Wong, R.W.; Yeung, S.S.; Kung, A.W. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double-blind, placebo controlled study. J. Rheumatol. 2000, 27, 1759-1765.
119. Sambrook, P.; Henderson, N.K.; Keogh, A.; Maodonald, P.; Glanville, A.; Spratt P. Effect of calcitriol on bone loss after cardiac or lung transplantation. J. Bone. Min. Res. 2000, 15, 1818-1824.
120. Cooper L.; Clifton-Bligh P.; Nery M.L; Figtree, G.; Twigg, S.; Hibbert, E.; Robinson, B.G. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am. J. Clin. Nutr. 2003, 77, 1324-1329.
121. Meier, C.; Woitge, H.W.; Witte, K.; Lemmer, B.; Seibel, M.J. Supplementation with oral vitamin D3 and calciumduring winter season prevents seasonal bone loss: a randomized controlled open-label prospective trial. J. Bone. Min. Res. 2004, 19, 1221-1230.
122. Aloia J.F.; Talwar S.A.; Pollack S.; Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch. Inter. Med. 2005, 165, 1618-1623.
123. Mocanu, V.; Stitt, P.A.; Costan, A.R.; Voroniuc, O.; Zbranca, E.; Luca, V.; Vieth, R. Long-term effects of giving nursing home residents bread fortified with 125 μg [5000 IU] vitamin D3 per daily serving. Am. J. Clin. Nutr. 2009, 89, 1132-1137.
124. Nelson, D.A.; Barondess, D.A.; Hendrix, S.L.; Beck, T.J. Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J. Bone. Miner. Res. 2000, 15, 1992-1997.
125. Aloia, J.F.; Mikhail, M.; Pagan, C.D.; Arunachalam, A.; Yeh, J.K.; Flaster, E. Biochemical and hormonalvariables in black and white women matched for age and weight. J. Lab. Clin. Med. 1998, 132, 383-389.
126. Gillespie, L.D.; Gillespie, W.J.; Robertson, M.C.; Lamb, S.E.; Cumming, R.G.; Rowe, B.H. Interventions for preventing falls in elderly people. Cochrane Database Syst. Rev. 2003, 4, CD000340.
127. Boland, R. Role of vitamin D in skeletal muscle function. Endocr. Rev. 1986, 7, 434-438.
128. Pfeifer, M.; Begerow, B.; Minne, H.W.; Schlotthauer, T.; Pospeschill, M.; Scholz, M.; Lazarescu, A.D.; Pollähne, W. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp. Clin. Endocrinol. Diabetes. 2001, 109, 87-92.
129. Costa, E.M.; Blau, H.M.; Feldman, D. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 1986, 119, 2214-2220.
130. Simpson, R.U.; Thomas, G.A.; Arnold, A.J. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J. Biol. Chem. 1985, 260, 8882-8891.
131. Sorensen, O.H.; Lund, B.; Saltin, B.; Lund, B.; Andersen, R.B.; Hjorth, L.; Melsen, F.; Mosekilde, L. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin. Sci. (Lond). 1979, 56, 157-161.
132. McComas, A.J. Skeletal muscle: form and function. Champaign: Human Kinetics 1996, pp. 62-65.
133. Bischoff-Ferrari, H.A.; Dietrich, T.; Orav, J.E.; Hu, F.B.; Zhang, Y.; Karlson, E.W.; Dawson-Hughes, B. Higher 25-hydroxy vitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >60 yrs. Am. J. Clin. Nutr. 2004, 80, 752-728.
134. Glerup, H.; Mikkelsen, K.; Poulsen, L.; Hass, E.; Overbeck, S.; Andersen, H.; Charles, P.; Eriksen, E.F. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif. Tissue. Int. 2000, 66, 419-424.
135. Grady, D.; Halloran, B.; Cummings, S. 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial. J. Clin. Endocrinol. Metab. 1991, 73, 1111-1117.
136. Latham, N.K.; Anderson, C.S.; Lee, A.; Bennett, D.A.; Moseley, A.; Cameron, I.D. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail people: the Frailty Interventions Trial in Elderly Subjects [FITNESS. J. Am. Geriatr. Soc. 2003, 51, 291-299.
137. Gerdhem, P.; Ringsberg, K.A.M.; Obrant, K.J.; Akesson, K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the propective population-based OPRA study of elderly women. Osteoporos. Int. 2005, 16, 1425-1431.
138. Houston, D.K.; Cesari, M.; Ferruci, L.; Cherubini, A.; Maggio, D.; Bartali, B.; Johnson, M.A.; Schwartz, G.G.; Kritchevsky, S.B. Association between vitamin D and physical performance: The InCHIANTI study. J. Gerontol. 2007, 62, 440-446.
139. Garber, A.J. Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J. Clin. Invest. 1983, 71, 1806-1821.
140. Mitnick, M.A.; Grey, A.; Masiukiewicz, U.; Bartkiewicz, M.; Rios-Velez, L.; Friedman, S.; Xu, L.; Horowitz, M.C.; Insogna, K. Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am. J. Physiol. Endocrinol. Metab. 2001, 280, E405-E412.
141. Han, K.O.; Choi, J.T.; Moon, I.G.; Jeong, M.S.; Yim, C.H.; Chung, H.Y.; Jang, H.C.; Yoon, H.K.; Han, I.K. Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women. Bone 2002, 31, 612-615.
142. Graafmans, W.C.; Ooms, M.E.; Hofstee, H.M.; Bezemer, P.D.; Bouter, L.M.; Lips P. Falls in the elderly: a prospective study of risk factors and risk profiles. Am. J. Epidemiol. 1996, 143, 1129-1136.
143. Broe, K.E.; Chen, T.C.; Weinberg, J.; Bischoff-Ferrari, H.A.; Holick, M.F.; Kiel, D.P. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J. Am. Geriatr. Soc. 2007, 55, 234-239.
144. Pfeifer, M.; Begerow B.; Minne, H.W.; Abrams, C.; Nachtigall, D.; Hansen, C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J. Bone. Miner. Res. 2000, 15, 1113-1118.
145. Bischoff H.A.; Stahelin H.B.; Dick W.; Akos, R.; Knecht, M.; Salis, C.; Nebiker, M.; Theiler, R.; Pfeifer, M.; Begerow, B.; Lew, R.A.; Conzelmann, M. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J. Bone. Miner. Res. 2003, 18, 43-351.
146. Dukas, L.; Bischoff, H.A.; Lindpaintner, L.S.; Schacht, E.; Birkner-Binder, D.; Damm, T.N.; Thalmann, B.; Stähelin, H.B. Alfacalcidol reduces the number of fallers in a communitydwelling elderly population with a minimum calcium intake of more than 500 mg daily. J. Am. Geriatr. Soc. 2004, 52, 230-236.
147. Flicker, L.; MacInnis, R.J.; Stein, M.S.; Scherer, S.C.; Mead, K.E.; Nowson, C.A.; Thomas, J.; Lowndes, C.; Hopper J.L.; Wark, J.D. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J. Am. Geriatr. Soc. 2005, 53, 1881-1888.
148. Bischoff-Ferrari, H.A.; Orav, E.J.; Dawson-Hughes, B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial, Arch. Intern. Med. 2006, 166, 424-430.
149. Pfeifer, M.; Begerow, B.; Minne, H.W.; Suppan, K.; Fahrleitner-Pammer, A.; Dobnig, H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos. Int. 2009, 20, 315-322.
150. Bischoff-Ferrari, H.A; Dawson-Hughes, B.; Willett, W.C. Effect of Vitamin D on Falls: A Meta-analysis. JAMA 2004, 291, 16.
151. Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Staehelin, H.B.; Orav, J.E.; Stuck, A.E.; Theiler, R.; Wong, J.; Egli, A.; Kiel, D.; Henschkowski, J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339, 3692.
152. Agrawal, S.; Krueger, D.; Engelke, J.A.; Nest, L.; Krause, P.; Drinka, P.; Binkley, N. Vitamin D status, risedronate and bone turnover in nursing home residents. J. Am. Geriatr. Soc. 2006, 54, 790-795.
153. Linton, P.J.; Dorshkind, K. Age-related changesin lymphocyte development and function. Nat. Immunol. 2004, 5, 133-139.
154. Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340, 448-454.
155. Clowes, J.A.; Riggs, B.L.; Khosla, S. The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev. 2005, 208, 207-227.
156. Jilka, R.L.; Hangoc, G.; Girasole, G.; Passeri, G.; Williams, D.C.; Abrams, J.S.; Boyce, B.; Broxmeyer, H.; Manolagas, S.C. Increased osteoclast development after oestrogen loss: mediation by interleukin-6. Science 1992, 257, 88-91.
157. Collin-Osdoby, P.; Rothe L.; Anderson, F. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J. Biol. Chem. 2001, 276, 20659-20672.
158. Bendixen A.C.; Shevde N.K.; Dienger K.M.; Willson T.M.; Funk C.D.; Pike J.W. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc. Natl. Acad. Sci. USA 2001, 98, 2443-2448.
159. Bertolini, D.R.; Nedwin, G.E.; Bringman, T.S.; Smith, D.D.; Mundy, D.D. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 1986, 319, 516-518.
160. Wei, S.; Kitaura, H.; Zhou, P.; Patrick, R.F.; Teitelbaum, S.L. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 2005, 115, 2.
161. Ershler, W.B.; Keller, E.T. Age-associated increased interleukin-6 gene expression,late-life diseases, and frailty. Annu. Rev. Med. 2000, 51, 245-270.
162. Takeuchi Y.; Watanabe S.; Ishii G.; Takeda S.; Nakayama K.; Fukumoto S.; Kaneta, Y.; Inoue, D.; Matsumoto, T.; Harigaya, K. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J. Biol. Chem. 2002, 277, 49011-49018.
163. Palmqvist, P.; Persson, E.; Conaway, H.H.; Lerner, U.H. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J. Immunol. 2002, 169, 3353-3362.
164. Ding, C.; Parameswaran, V.; Udayan, R.; Burgess, J.; Jones, G. Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study. J. Clin. Endocrinol. Metab. 2008, 93, 1952-1958.
165. Scheidt-Nave, C.; Bismar, H.; Leidig-Bruckner, G.; Woitge, H.; Seibel, M.J.; Ziegler, R.; Pfeilschifter, J. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J. Clin. Endocrinol. Metab. 2001, 86, 2032-2042.
166. McKane, W.R.; Khosla, S.; Peterson, J.M.; Egan, K.; Riggs, B.L. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J. Bone. Miner. Res. 1994, 9, 1313-1318.
167. Kania, D.M.; Binkley, N.; Checovich, M.; Havighurst, T.; Schilling, M.; Ershler, W.B. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J. Am. Geriatr. Soc. 1995, 43, 236-239.
168. Abrahamsen, B.; Bonnevie-Nielsen, V.; Ebbesen, E.N.; Gram, J.; Beck-Nielsen, H. Cytokines and bone loss in a 5-year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J. Bone. Miner. Res. 2000, 15, 1545-1554.
169. Nanes, M.S. Tumor necrosis factor- α: molecular and cellular mechanisms in skeletal pathology. Gene 2003, 321, 1-15.
170. Gaffen, S. L. Biology of recently discovered cytokines: interleukin- 17-a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis. Res. Ther. 2004, 6, 240-247.
171. Goswami, J.; Hernández-Santos, N.; Zuniga, L.A.; Gaffen, S.L. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss Europ. J. Immun. 2009, 39, 2831-2839.
172. Kim J.G.; Lim K.S.; Ku S.Y.; Kim S.H.; Choi Y.M.; Moon S.Y. Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women. J. Bone. Miner. Metab. 2006, 24, 53-57.
173. Langdahl, B.L.; Løkke, E.; Carstens, M.; Stenkjaer, L.L.; Eriksen, E.F. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res. 2000, 15, 402-414.
174. Han, K.O.; Choi, J.T.; Moon, I.G.; Jeong, M.S.; Yim, C.H.; Chung, H.Y.; Jang, H.C.; Yoon, H.K.; Han, I.K. Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women. Bone 2002, 31, 612-615.
175. Ferrari, S.L.; Ahn-Luong, L.; Garnero, P.; Humphries, S.E.; Greenspan, S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J. Clin. Endocrinol. Metab. 2003, 88, 255-259.
176. Ferrari, L.S.; Karasik, D.; Liu, J.; Karamohamed, S.; Herbert, A.G.; Cupples, L.; Kiel, P.D. Interactions of Interleukin-6 Promoter Polymorphisms With Dietary and Lifestyle Factors and Their Association With Bone Mass in Men and Women From the Framingham Osteoporosis Study. J. Bone. Miner. Res. 2004, 19, 552-559.
177. Spotila, L.D.; Rodriguez, H.; Koch, M.; Adams, K.; Caminis, J.; Tenenhouse, H.S.; Tenenhouse, A. Association of a polymorphism in the TNFR2 gene with low bone mineral density. J. Bone. Miner. Res. 2000, 15, 1376-1383.
178. Albagha, O.M.E.; Tasker, P.N.; McGuigan, F.E.A.; Reid, D.M.; Ralston, S.H. Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum. Mol. Genet. 2002, 11, 2289-2295.
179. Hutter, C.; Laing, P. Multiple sclerosis: sunlight, diet, immunology and aetiology. Med. Hypotheses. 1996, 46, 67-74.
180. Merlino, L.A.; Curtis, J.; Mikuls, T.R.; Cerhan, J.R.; Criswell, L.A.; Saag, K.G. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis. Rheum. 2004, 50, 72-77.
181. Veldman, C.M.; Cantorna, M.T.; DeLuca, H.F. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch. Biochem. Biophys. 2000, 15, 334-338.
182. De Luca, H.F.; Cantorna, M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001, 15, 2579-2585.
183. Muller, K.; Haahr, P.M.; Diamant, M. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992, 4, 506-512.
184. Evans, K.N.; Nguyen, L.; Chan, J.; Innes, B.A.; Bulmer, J.N.; Kilby, M.D.; Hewison, M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol. Reprod. 2006, 75, 816-822.
185. Zhu, Y.; Mahon, B.D.; Froicu, M.; Cantorna, M.T. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol. 2005, 35, 217-224.
186. Schleithoff, S.S.; Zittermann, A.; Tenderich, G.; Berthold, H.K.; Stehle, P.; Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 2006, 83, 754-759.
187. Mahon, B.D.; Gordon, S.A.; Cruz, J.; Cosman, F.; Cantorna, M.T. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J. Neuroimmunol. 2003, 134, 128-132.
188. Inanir, A.; Ozoran, K.; Tutkak, H.; Mermerci, B. The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. J. Int. Med. Res. 2004, 32, 570-582.